BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fincham REA, Delvecchio FR, Goulart MR, Yeong JPS, Kocher HM. Natural killer cells in pancreatic cancer stroma. World J Gastroenterol 2021; 27(24): 3483-3501 [PMID: 34239264 DOI: 10.3748/wjg.v27.i24.3483]
URL: https://www.wjgnet.com/1007-9327/full/v27/i24/3483.htm
Number Citing Articles
1
Yu-Hsuan Hung, Li-Tzong Chen, Wen-Chun Hung. The Trinity: Interplay among Cancer Cells, Fibroblasts, and Immune Cells in Pancreatic Cancer and Implication of CD8+ T Cell-Orientated TherapyBiomedicines 2022; 10(4): 926 doi: 10.3390/biomedicines10040926
2
Duancheng Guo, Longyun Ye, Weiding Wu, Xianjun Yu, Kaizhou Jin. Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancerActa Biochimica et Biophysica Sinica 2023; 55(6): 923 doi: 10.3724/abbs.2023045
3
Nicky A. Beelen, Merel R. Aberle, Virginia Bruno, Steven W. M. Olde Damink, Gerard M. J. Bos, Sander S. Rensen, Lotte Wieten. Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response against patient-derived pancreatic cancer organoidsFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1133796
4
Martina S. Lutz, Kevin Wang, Gundram Jung, Helmut R. Salih, Ilona Hagelstein. An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancerFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1343929
5
Catarina Nascimento, Andreia Gameiro, Jorge Correia, João Ferreira, Fernando Ferreira. The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical ImplicationsCells 2022; 11(16): 2578 doi: 10.3390/cells11162578
6
Praveen Bhoopathi, Padmanabhan Mannangatti, Swadesh K. Das, Paul B. Fisher, Luni Emdad. Pancreatic Cancer: Basic Mechanisms and TherapiesAdvances in Cancer Research 2023; 159: 285 doi: 10.1016/bs.acr.2023.02.010
7
Wei Liu, Dongwei Hu, Jinjie Li, Qigang Xu, Zongjing Chen, Bo Xu. CSTF2T facilitates pancreatic adenocarcinoma growth and metastasis by elevating H3K4Me1 methylation of CALB2 via ASH2LCancer Biology & Therapy 2023; 24(1) doi: 10.1080/15384047.2023.2216041
8
Hyun-Ah Kim, Hyunsoo Kim, Min-Kyung Nam, Jong Kook Park, Moo-Yeal Lee, Seok Chung, Kyung-Mi Lee, Hyo-Jeong Kuh. Suppression of the antitumoral activity of natural killer cells under indirect coculture with cancer-associated fibroblasts in a pancreatic TIME-on-chip modelCancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03064-9
9
Sofian Benkhaled, Cedric Peters, Nicolas Jullian, Tatjana Arsenijevic, Julie Navez, Dirk Van Gestel, Luigi Moretti, Jean-Luc Van Laethem, Christelle Bouchart. Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy?Cancers 2023; 15(3): 768 doi: 10.3390/cancers15030768
10
Virender Kumar, Ram I. Mahato. Natural killer cells for pancreatic cancer immunotherapy: Role of nanoparticlesCancer Letters 2023; 579: 216462 doi: 10.1016/j.canlet.2023.216462
11
Qi Lu, Tian Liu, Zeyu Han, Jian Zhao, Xiaoyuan Fan, Helin Wang, Jiaxuan Song, Hao Ye, Jin Sun. Revolutionizing cancer treatment: The power of cell-based drug delivery systemsJournal of Controlled Release 2023; 361: 604 doi: 10.1016/j.jconrel.2023.08.023
12
Patrick V. Lawrence, Krisha Desai, Christopher Wadsworth, Nagina Mangal, Hemant M. Kocher, Nagy Habib, Anguraj Sadanandam, Mikael H. Sodergren. A Case Report on Longitudinal Collection of Tumour Biopsies for Gene Expression-Based Tumour Microenvironment Analysis from Pancreatic Cancer Patients Treated with Endoscopic Ultrasound Guided Radiofrequency AblationCurrent Oncology 2022; 29(10): 6754 doi: 10.3390/curroncol29100531
13
Zhenglin Ou, Yebin Lu, Dayong Xu, Zhen Luo. Hypoxia mediates immune escape of pancreatic cancer cells by affecting miR-1275/AXIN2 in natural killer cellsFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1271603